Picture of Scandinavian ChemoTech AB logo

CMOTEC B Scandinavian ChemoTech AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: ChemoTech: Outcome Of Directed Issue

May 19 (Reuters) - Scandinavian ChemoTech AB CMOTECb.ST:

CHEMOTECH ANNOUNCES OUTCOME OF THE DIRECTED ISSUE

ISSUES 761,191 NEW CLASS A SHARES TOTALING ABOUT SEK 2.55 MILLION

SUBSCRIPTION PRICE SET AT SEK 3.35 PER CLASS A SHARE, 10% DISCOUNT TO VWAP

Source text: ID:nWkr7HrBVW

Further company coverage: [CMOTECb.ST]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Scandinavian ChemoTech AB

See all news